PCSK9 and metabolic dysfunction-associated steatohepatitis: We report on the important morphological and molecular comparison of hepatic inflammatory and fibrotic changes as well as alterations in cholesterol metabolism-related proteins involving PCSK9 in middle-aged male and female mice upon NASH development in the CDAA diet-induced model.